Is there a peripheral site of action contributing to the voiding effects of α2-adrenoceptor agonists and antagonists?
- 7 June 2014
- journal article
- Published by Springer Nature in World Journal of Urology
- Vol. 33 (3) , 433-440
Abstract
Since it has not been established whether there is an effect on voiding exerted by direct stimulation or blockade of α2-adrenoceptors in the bladder and urethra, MK-467, a peripherally acting α2-adrenoceptor antagonist not penetrating into the CNS, was used to test whether part of the voiding effects of systemically given α2-adrenoceptor agonists is peripheral. Urodynamic recordings from 27 conscious male adult C57/Bl J-strain mice were performed. After vehicle (saline) administration, two groups of animals were treated first with the selective α2-adrenoceptor agonist dexmedetomidine (Dex) and then with the selective α2-adrenoceptor antagonists atipamezole (Ati) or MK-467. Two other groups were first treated with Ati or MK-467 and then with Dex. Treatment with vehicle or α2-adrenoceptor antagonists alone did not affect micturition parameters. All animals treated first with Dex-developed overflow incontinence. Treatment with Ati after Dex reversed almost totally the effects of Dex on all voiding parameters, but treatment with MK-467 after Dex showed no detectable improvement. Treatment with Dex after Ati had no effect on any voiding parameter except maximal pressure. When mice were treated with Dex after MK-467, overflow incontinence was produced in seven of eight animals studied. The absence of functionally relevant peripheral effects on voiding mediated via α2-adrenoceptors is supported by the finding that neither Ati nor MK-467 alone had any effect on micturition parameters and by the inability of MK-467 to inhibit the effects of Dex, suggesting that the relevant Dex effects were exerted within the CNS.Keywords
This publication has 22 references indexed in Scilit:
- Cardiopulmonary and sedative effects of the peripheral α2-adrenoceptor antagonist MK 0467 administered intravenously or intramuscularly concurrently with medetomidine in dogsAmerican Journal of Veterinary Research, 2012
- Voiding effects mediated by α 2 ‐adrenoceptors in the anaesthetized male ratBJU International, 2010
- Pharmacology of α1-adrenoceptor antagonists in the lower urinary tract and central nervous systemNature Reviews Endocrinology, 2007
- α1‐, α2‐ and β‐adrenoceptors in the urinary bladder, urethra and prostateBritish Journal of Pharmacology, 2006
- Pharmacology of the Lower Urinary Tract: Basis for Current and Future Treatments of Urinary IncontinencePharmacological Reviews, 2004
- CYSTOMETRIC EVALUATION OF BLADDER FUNCTION IN NON-ANESTHETIZED MICE WITH AND WITHOUT BLADDER OUTLET OBSTRUCTIONJournal of Urology, 2000
- The role of spinal and peripheral α 1 ‐ and α 2 ‐adrenoceptors on bladder activity induced by bladder distension in anaesthetized ratBJU International, 2000
- EVIDENCE FOR PREDOMINANT MEDIATION OF α 1 -ADRENOCEPTOR IN THE TONUS OF ENTIRE URETHRA OF WOMENJournal of Urology, 1999
- Role of Spinal and Peripheral Alpha sub 2 Adrenoceptors in Micturition in Normal Conscious RatsJournal of Urology, 1996
- Dexmedetomidine Produces a Hypnotic–Anesthetic Action in Rats via Activation of Central Alpha-2 AdrenoceptorsAnesthesiology, 1989